Showing results (291-300 of 316) with videos related to

Sort By:
Pageof 32
The Journal of Biological Chemistry|June 6, 2006
Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restrictionWeiping Qin, Tianle Yang, Lap Ho, et al.
Neuroimage|September 11, 2020
Multi-centre, multi-vendor reproducibility of 7T QSM and R<sub>2</sub>* in the human brain: Results from the UK7T studyCatarina Rua, William T Clarke, Ian D Driver, et al.
ESC Heart Failure|May 7, 2021
Design and rationale of the EMPA-VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failureMoritz J Hundertmark, Olorunsola F Agbaje, Ruth Coleman, et al.
Psychiatric Services (Washington, D.C.)|November 14, 2023
Disparities in COVID-19-Related Psychological Distress Among Recipients of a State's Public Mental Health ServicesAmy Ehntholt, Ian T Rodgers, Helen-Maria Lekas, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
Path integration selectively predicts midlife risk of Alzheimer's diseaseCoco Newton, Marianna Pope, Catarina Rua, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 29, 2024
Entorhinal-based path integration selectively predicts midlife risk of Alzheimer's diseaseCoco Newton, Marianna Pope, Catarina Rua, et al.
European Heart Journal|September 23, 2015
Cardiac energetics, oxygenation, and perfusion during increased workload in patients with type 2 diabetes mellitusEylem Levelt, Christopher T Rodgers, William T Clarke, et al.
NMR in Biomedicine|March 29, 2019
Localized rest and stress human cardiac creatine kinase reaction kinetics at 3 TWilliam T Clarke, Mark A Peterzan, Jennifer J Rayner, et al.
Diagnostics (Basel, Switzerland)|November 27, 2024
Demonstration of T-Cell Monotypia Using Anti-TCRbeta1/2 (<i>TRBC1</i>/2) Immunostaining as a Rapid and Cost-Effective Alternative to PCR-Based Clonality Studies for the Diagnosis of T-Cell LymphomaElizabeth J Soilleux, Daniel T Rodgers, Jinlong J Situ, et al.
BMJ Open|July 29, 2025
Noradrenaline for progressive supranuclear palsy syndromes (NORAPS): a randomised, double-blind, placebo-controlled, crossover Phase IIb clinical trial evaluating the efficacy and safety of oral atomoxetine for treating cognitive and behavioural changes in people with progressive supranuclear palsy syndromes in the UKRobert Durcan, Hugo Paula, Boyd C P Ghosh, et al.
Pageof 32